The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine-Reference-Cited by-同舟云学术

The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine

Published:2016-01 Issue: Volume:8 Page:BIC.S37548
ISSN:1179-299X
Container-title:Biomarkers in Cancer
language:en
Short-container-title:Biomark�Cancer

Author:

Fiore Louis D.¹,Brophy Mary T.¹,Turek Sara¹,Kudesia Valmeek¹,Ramnath Nithya²,Shannon Colleen¹,Ferguson Ryan¹,Pyarajan Saiju¹,Fiore Melissa A.¹,Hornberger John³⁴,Lavori Philip⁵⁶

Affiliation:

1. Massachusetts Veterans Epidemiology Research and information Center (MAVERIC), Veterans Affairs Boston Healthcare System, Department of Veterans Affairs Office of Research and Development–-Cooperative Studies Program, Washington DC, USA.

2. VA Ann Arbor Healthcare System, the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.

3. Cedar Associates, Menlo Park, CA, USA.

4. Department of Medicine, Stanford University, Stanford, CA, USA.

5. Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.

6. Department of Statistics, Stanford University, Stanford, CA, USA.

Abstract

The Department of Veterans Affairs (VA) recognized the need to balance patient-centered care with responsible creation of generalizable knowledge on the effectiveness of molecular medicine tools. Embracing the principles of the rapid learning healthcare system, a new clinical program called the Precision Oncology Program (POP) was created in New England. The POP integrates generalized knowledge about molecular medicine in cancer with a database of observations from previously treated veterans. The program assures access to modern genomic oncology practice in the veterans affairs (VA), removes disparities of access across the VA network of clinical centers, disseminates the products of learning that are generalizable to non-VA settings, and systematically presents opportunities for patients to participate in clinical trials of targeted therapeutics.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.4137/BIC.S37548

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons;Molecular Case Studies;2023-11-22

2. Extending the vision of adaptive point-of-care platform trials to improve targeted use of drug therapy regimens: An agile approach in the learning healthcare system toolkit;Contemporary Clinical Trials;2023-10

3. The use and role of digital technology in learning health systems: A scoping review;International Journal of Medical Informatics;2023-10

4. The role of genetic testing in the prognosis and management of solid tumors. A literature review;Revista Romana de Medicina de Laborator;2023-07-01

5. Practical issues in pragmatic trials: the implementation of the Diuretic Comparison Project;Clinical Trials;2023-03-29